Stimcell Energetics Reports $265,602 Net Loss and Increased Operating Expenses for Q3 2025

Stimcell Energetics Inc. reported a net loss of $265,602 for the three months ending August 31, 2025, compared to a loss of $66,919 during the same period in 2024. The company's total operating expenses surged to $252,354, a significant increase from $59,636 in the prior year, primarily driven by a rise in general and administrative expenses, which escalated to $139,484 from $16,451. The increase in expenses reflects the company's ongoing investments in research and development, which amounted to $57,309, marking a new line of expenditure for the firm.

In terms of financial position, Stimcell's total assets decreased to $16,387,000 as of August 31, 2025, down from $21,222,000 at the end of May 2025. The company's liabilities also rose, totaling $1,410,336, compared to $1,267,508 in the previous fiscal period. The accumulated deficit increased to $11,127,158, up from $10,861,556, indicating ongoing challenges in achieving profitability. The company’s cash reserves dwindled to $6,437 from $14,581, reflecting a cash outflow of $108,142 from operating activities during the quarter.

Stimcell Energetics has made strategic moves, including the issuance of 375,000 shares for services, which contributed to an increase in additional paid-in capital to $9,266,216 from $9,146,591. The company also underwent a reverse stock split on November 1, 2024, reducing its authorized shares from 7.5 billion to 500 million, a move aimed at improving its stock price and market perception. The weighted average number of shares outstanding rose to 20,319,261 from 19,815,758, reflecting the share issuance.

Operationally, the company has not reported specific metrics regarding customer counts or product adoption rates in this filing. However, it continues to rely on related party transactions for financing, with amounts due to related parties increasing to $493,628 from $448,536. The company has indicated that it plans to secure additional funding through loans from directors and officers, as well as potential private placements of common stock, to support its operations and growth initiatives.

Looking ahead, Stimcell Energetics acknowledges substantial doubt regarding its ability to continue as a going concern, contingent on its ability to secure necessary financing and achieve profitable operations. The management's focus remains on obtaining funding and advancing its product development efforts, with the expectation that these initiatives will eventually lead to improved financial performance. The company’s future results will depend on its ability to navigate these challenges and capitalize on market opportunities in the biotech sector.